THE SINGLE BEST STRATEGY TO USE FOR CONOLIDINE

Our profiling and comparison in the actions of conolidine and cannabidiol with recognized pharmacological brokers predicted a MOA shared with Cav2.2 channel blocker, ω-conotoxin CVIE.2020). ACKR3 capabilities as a 'scavenger' that 'traps' the secreted opioids and stops them from binding towards the classical receptors, thus dampening their analges